Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLeonaBio Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$3.73 | -$0.83 | -$2.28 |
| Q2 2026 | 2 | -$1.39 | -$1.39 | -$1.39 |
| Q3 2026 | 2 | -$0.69 | -$0.69 | -$0.69 |
| Q4 2026 | 2 | -$0.60 | -$0.60 | -$0.60 |
| Q1 2027 | 1 | -$0.76 | -$0.76 | -$0.76 |
| Q2 2027 | 1 | -$0.79 | -$0.79 | -$0.79 |
| Q3 2027 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q4 2027 | 1 | -$0.71 | -$0.71 | -$0.71 |
LeonaBio Inc. Earnings Date And Information
LeonaBio Inc. last posted its earnings results on Friday, August 14th, 2026. The company reported $-0.8 earnings per share for the quarter, topping analysts' consensus estimates of $-1.39 by $0.59. The company had revenue of 0 for the quarter and had revenue of 0 for the year. LeonaBio Inc. has generated $-25 earnings per share over the last year ($-24.7 diluted earnings per share) and currently has a price-to-earnings ratio of -0.19. LeonaBio Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
LeonaBio Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2026 | Q2 2026 | -$1.39 | -$4.45 | -3.06 | $0 | $0 |
| 05/07/2026 | Q1 2026 | -$2.28 | -$7.71 | -5.43 | $0 | $0 |
| 03/31/2026 | Q4 2025 | N/A | -$18.94 | N/A | $0 | $0 |
| 11/06/2025 | Q3 2025 | -$1.06 | -$1.68 | -0.62 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$1.80 | -$1.78 | 0.02 | N/A | $0 |
| 05/09/2025 | Q1 2025 | -$2.00 | -$2.30 | -0.3 | N/A | $0 |
| 02/27/2025 | Q4 2024 | -$0.45 | -$3.90 | -3.45 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.80 | -$7.50 | -6.7 | N/A | $0 |
| 08/01/2024 | Q2 2024 | N/A | -$7.00 | N/A | N/A | $0 |
| 05/15/2024 | Q1 2024 | -$0.79 | -$6.90 | -6.11 | N/A | $0 |
| 02/22/2024 | Q4 2023 | -$0.96 | -$7.20 | -6.24 | N/A | $0 |
| 11/09/2023 | Q3 2023 | N/A | -$8.70 | N/A | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.78 | -$7.80 | -7.02 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.62 | -$6.80 | -6.18 | N/A | $0 |
| 03/23/2023 | Q4 2022 | N/A | -$6.80 | N/A | N/A | $0 |
| 11/10/2022 | Q3 2022 | -$0.64 | -$4.30 | -3.66 | N/A | $0 |
| 08/15/2022 | Q2 2022 | -$0.64 | -$6.50 | -5.86 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.55 | -$4.90 | -4.35 | N/A | $0 |
| 03/28/2022 | Q4 2021 | N/A | -$4.40 | N/A | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$5.00 | -$4.20 | 0.8 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LeonaBio Inc. Earnings: FAQ's
In the previous quarter, LeonaBio Inc. (:LONA) reported $-0.8 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.39 by $0.59.
The conference call for LeonaBio Inc.'s latest earnings report can be listened to online.
The conference call transcript for LeonaBio Inc.'s latest earnings report can be read online.
LeonaBio Inc. (:LONA) has a recorded net income of $-105,609,000.LeonaBio Inc. has generated $-24.7 earnings per share over the last four quarters.
LeonaBio Inc. (:LONA) has a price-to-earnings ratio of -0.19 and price/earnings-to-growth ratio is 0.